Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WuXi XDC CaymanHKSE:02268 +1.86%50 Interest Coverage is 93.62 as of Dec. 2025, which is 55% below its 10-year median of 208.93. GuruFocus rates HKSE:02268 with a GF Score™ of 50/100. The stock has 3 warning signs investors should review. Among 93 Medical Diagnostics & Research companies, WuXi XDC Cayman ranks better than 83.87% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. WuXi XDC Cayman's
Operating Income
for the
six
months ended in Dec. 2025 was HK$961 Mil. WuXi XDC Cayman's Interest Expense for the
six
months ended in Dec. 2025 was HK$-10 Mil.
WuXi XDC Cayman's interest coverage for the quarter that ended in Dec. 2025 was 93.62.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. WuXi XDC Cayman Inc has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for WuXi XDC Cayman's Interest Coverage or its related term are showing as below:
HKSE:02268'
s Interest Coverage Range Over the Past 10 Years
Min: 48.59 Med: 208.93 Max: No Debt
Current: 99.03
HKSE:02268's Interest Coverage is ranked better than 83.87% of 93
companies
in the Medical Diagnostics & Research industry
Industry Median: 10.23
vs HKSE:02268: 99.03
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
WuXi XDC Cayman Interest Coverage Related Terms
WuXi XDC Cayman Interest Coverage Historical Data
* Premium members only.
The historical data trend for WuXi XDC Cayman's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HKSE:02268 vs TMO, DHR, NTRA: Interest Coverage Comparison
For the Diagnostics & Research subindustry, WuXi XDC Cayman's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WuXi XDC Cayman Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Interest Coverage distribution charts can be found below:
* The bar in red indicates where WuXi XDC Cayman's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WuXi XDC Cayman (HKSE:02268) has a Interest Coverage of 93.62 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on WuXi XDC Cayman and its competitors. This is 55% below median its historical median of 208.93. Over the past decade, WuXi XDC Cayman's Interest Coverage has ranged from 48.59 to 10,000.00. According to the industry distribution chart, WuXi XDC Cayman ranks #15 out of 93 companies in the Medical Diagnostics & Research industry, placing it in the top 16.1%.
Is WuXi XDC Cayman's Interest Coverage too high?
WuXi XDC Cayman's current Interest Coverage of 93.62 is 55% below median its 10-year median of 208.93. Over the past 10 years, this metric has ranged from a low of 48.59 to a high of 10,000.00. The Medical Diagnostics & Research industry median Interest Coverage is 10.23. WuXi XDC Cayman's value of 93.62 is 815.2% above this industry median. Based on the distribution chart, WuXi XDC Cayman ranks #15 out of 93 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, WuXi XDC Cayman has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, WuXi XDC Cayman ranks #15 out of 93 companies for Interest Coverage. This places WuXi XDC Cayman in the top 16% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 10.23. WuXi XDC Cayman's value of 93.62 is 815.2% above this benchmark. Historically, WuXi XDC Cayman's own Interest Coverage has ranged from 48.59 to 10,000.00 over the past decade. While the company's 10-year median is 208.93 vs. the industry median of 10.23, WuXi XDC Cayman has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 10.23, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WuXi XDC Cayman's current Interest Coverage of 93.62 is 815.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on WuXi XDC Cayman and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 10.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WuXi XDC Cayman's current Interest Coverage is 93.62, which is 55% below median its own 10-year median of 208.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (HKSE:02268) has a current Interest Coverage of 93.62. The current Interest Coverage is 93.62, which is 55% below median its 10-year median of 208.93 and 815.2% above the Medical Diagnostics & Research industry median of 10.23. WuXi XDC Cayman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For WuXi XDC Cayman (HKSE:02268), the current Interest Coverage is 93.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
50GF Score
Get the complete analysis for HKSE:02268
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02268 has been successfully added to your 
